Your session is about to expire
← Back to Search
cTBS for PTSD
Study Summary
This trial will test if a non-invasive brain intervention can reduce the risk of developing PTSD after a traumatic event.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am within the specified age range for the trial.I do not have current symptoms of psychosis or bipolar disorder.I have no history of muscle, bone, or nerve diseases.I haven't taken any drugs recently that affect brain function or learning.I have no health issues that prevent me from undergoing TMS or MRI.I have been diagnosed with PTSD.I am willing to participate in the study.I have no history of muscle, bone, or nerve diseases.I have been diagnosed with PTSD.
- Group 1: cTBS: Inhibitory Transcranial magnetic stimulation (TMS) to sensory Cortex
- Group 2: Sham cTBS
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could I take part in this research if I qualify?
"This study requires 66 individuals that have PTSD, are aged 18-65, and meet the following prerequisites: Being able to comprehend and sign informed consent forms, a willingness to participate in the trial itself, no past medical history of neurological diseases or muscular skeletal impairments, finally, a clinical diagnosis of PTSD for people who hope to be in the PTSD group."
Are there positions available in this trial for willing participants?
"According to the latest information on clinicaltrials.gov, this study is no longer looking for participants. The trial was first posted on 1/1/2023 and was last updated on 9/26/2022. There are, however,428 other trials that are still recruiting patients."
What are the goals of this research project?
"The primary outcome of this study is to assess changes in neural connections regional activation. This will be done over a Study Day 30 and 31 timeframe. The secondary outcomes include ECG, which is defined as heart rate and heart-rate variability (HRV) that will be measured using the ECG module of the BIOPAC system. One 5mm Ag/AgCl electrode will be placed on the chest above the right clavicle while another electrode is placed on the chest under the left side of the ribcage., Changes in Measures of skin conductive response, which is defined as Skin conductance response (SCR)"
Are middle-aged individuals being sought out for this research?
"The trial's enrollment requirements state that potential patients must be aged between 18-65."
Who else is applying?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger